Model for End-stage Liver Disease and Model for End-stage Liver Disease-Na Scores Predict Both Before-Listing and Wait-List Mortality
β Scribed by N. Yamashiki; Y. Sugawara; S. Tamura; J. Kaneko; K. Nojiri; T. Aoki; Y. Sakamoto; K. Hasegawa; K. Koike; N. Kokudo
- Book ID
- 113935423
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 435 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Candidates with fulminant hepatic failure (Status-1A) receive the highest priority for liver transplantation (LT) in the United States. However, no studies have compared wait-list mortality risk among end-stage liver disease (ESLD) candidates with high Model for End-Stage Liver Disease (MELD) scores
With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant